Moyamoya disease—a rare, progressive condition that narrows the brain's blood vessels—leads to an increased risk of stroke ...

Many people with IBD, an umbrella term that includes ulcerative colitis and Crohn's disease, have a reduced quality of life, ...

Pediatric infliximab biosimilar use has risen significantly, reflecting evolving treatment patterns in inflammatory bowel ...

Explore how the Specialty Medical Home model transforms care for patients with inflammatory bowel disease (IBD) by ...

Dr Ray O’Connor takes a look at the latest clinical articles on inflammatory bowel disease ...

Two years ago, 10-year-old Bo Bratschie experienced weight loss and high fevers, leading to many hospital visits before being ...

U.S. Food and Drug Administration (FDA) has approved a new presentation of STEQEYMA® (ustekinumab-stba), a biosimilar to STELARA® (ustekinumab), in a 45mg/0.5mL solution in a single-dose vial for ...

Design Prospectively recorded 1-year and 3-year questionnaires in children from the All Babies in Southeast Sweden and The Norwegian Mother, Father and Child Cohort Study were used to assess diet ...

Azathioprine is used for inflammatory bowel disease (IBD) therapy. Patients under 6 years of age (very early onset, VEO-IBD) showed distinctive clinical characteristics, such as increased activity of ...

Aminosalicylates are the mainstay of therapy in mild to moderately active ulcerative colitis (UC) but optimisation of therapy is needed. 1, 2 Mesalazine, both oral and topical (enema, foam, and ...

Objective Growing evidence suggests that coeliac disease (CeD) is more common in patients with inflammatory bowel disease (IBD) but diagnostic confusion remains due to overlapping histological and ...